Diabetes Management Technology Poses Issues with Older U.S. Populations
Image Source: AAFP
According to a report posted on Healio, recent studies have shown that there are challenges presented with continuous glucose monitoring devices (CGMs), including inaccurate results, device adhesion, and smartphone access to those with type 1 or 2 diabetes that are 50 to 85 years of age.
Understanding The Usability of Diabetes Technology Among Older Populations
Overall, there needs to be more education and understanding of how older populations interact with newer technologies that are less familiar to them.
Michael Weiner, MD, MPH, research scientist at the Center for Health Services Research at the Regenstrief Institute and the department of medicine at Indiana University, explains, “This is a whole area of health technology that needs study. There’s hardware involved, which is the device itself. There’s software involved, which is reading, organizing, interpreting and communicating the data from the device. Knowing how the technology works in the real world and the impact of the technology on usability and ultimately on health outcomes is important.”
As a result, a study has been conducted to provide healthcare professionals with more insight into the area of concern. Below are the results of said study.
Results of a Study on Older Populations’ Diabetes Device Management
Researchers enrolled ten adults with diabetes (seven Black adults and three white adults) aged 50 to 85 who were patients at an Indiana safety-net institution. In the 10-14 day study, the adults used a CGM, physical activity monitor, electronic medication bottles, and smartphones with prompts about behaviors and symptoms.
In this study, the participants had problems related to the failure of the continuous glucose monitor adhesive and reading the graphs on the devices.
In the study, the participants wore CGM adhesive devices and activity monitors. They also used smartphones and smart medication bottles for roughly the same time as the first study.
The second study's results showed that “73% of participants had hypoglycemia with a glucose level of 70 mg/dL or lower, and 42% had clinically significant hypoglycemia with a glucose level below 54 mg/dL. Hypoglycemia was also identified among eight participants by home-based blood glucose measurement.” A third of the smartphone prompts were also left unanswered, and nearly a third of the participants had trouble with the CGM device adhesive.
Researchers also concluded that the participant's worry or fear about low blood glucose was mainly unchanged.
How can healthcare professionals help older populations understand and improve the use of newer diabetes technologies?
Those in the U.S. diabetes community and the healthcare system need to understand that not all populations are knowledgeable about new technologies for diabetes care and the need for this proper care.
What is the solution to helping these older populations with newer, unfamiliar technologies?
The fundamental solution to eliminate a lack of understanding among the older population is to promote guided devices–meaning, devices that guide users step-by-step.
Follow Orange Biomed on social media to stay up-to-date on guided device solutions like OBM rapid A1c.